Back
About the Global Fund
Sixth Replenishment
People & Structures
Funding Model
�Investments & Results
-
Explore our data on investments and results in the fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
- Find a Grant (Old Grant Portfolio)
HIV & AIDS
Tuberculosis
MalariaNews & Stories
-
29 June 2019
Global Fund Praises UK for Increasing Pledge by 16 Percent -
24 June 2019
Global Fund Welcomes Japan’s Commitment to Save One Million Lives -
12 June 2019
Our Global Health Security is Only as Strong as our Weakest Link -
06 June 2019
Morocco: “Civil Society is Helping Us Reach Key Populations” -
More News & Stories
-
Newsroom & Media Contacts
Feature Stories
Updates
- Data Explorer Enhancements
- Message from the Executive Director – Follow-up audit for Democratic Republic of Congo
- Follow-up Audit of Global Fund Grants in the Democratic Republic of Congo
- Withdrawal of the Quality Assurance Information Notice 2016-02 regarding IPCA Ratlam Manufacturing Site
- Opportunity for Evaluation of Diagnostic Products
-
More Updates
Featured Publication
Documents By Type
Sourcing & Management of Health Products
Information Notice
The Global Fund’s quality assurance information notices provide guidance and advice on how to operationalize in practical terms the consequences of a quality or a safety issue related to a product that has been procured with Global Fund funds. The initial information, stated in the notice, comes from the manufacturer of health products in question and/or is confirmed by stringent regulatory mechanisms.
-
Information Notices
-
QA Information Notice 2019-06: Voluntary recall initiated by Macleods for ”Moxifloxacin Dispersible tablets 100mg - Batch No BMC5801A”
download in English -
QA Information Notice 2019-05: Unlawfully displayed ACTm logo on boxes of Artemether + Lumefantrine 20mg + 120mg bearing various manufacturer names found in Nigeria
download in English -
QA Information Notice 2019-04: Suspension of manufacturing activities at Micro Labs Limited, Kumbalgodu, ML08, Bangalore (India)
download in English -
QA Information Notice 2019-03: The Global Fund Position on the UK MHRA Statement of non-compliance with Good Manufacturing Practices (GMP) for Micro Labs Limited, Unit 3, Hosur (India)
download in English -
QA Information Notice 2019-02: Temporary suspension of procurement of Artesunate / Amodiaquine tablets, manufactured by Guilin Pharmaceuticals
download in English | Français -
QA Information Notice 2019-01: Quality issues with DawaPlus 2.0 commercialized by Tana Nettings Co Ltd manufactured by H. Sheikh Noorud - Din & Sons (HSNDS) - Revised version
download in English | Français -
QA Information Notice 2018-07: Suspension of Dongkuk Viet Nam Co., Ltd. from the WHO/UNFPA list of prequalified male latex condom manufacturer
download in English -
QA Information Notice 2018-06: Unlawfully displayed ACTm logo on boxes of Lesanto Laboratories
download in English -
QA Information Notice 2018-05-Falsified Combiart : Artemether 20 mg + Lumefantrine 120 mg tablets
download in English -
Quality Assurance Information Notice 2018-03 (update 1 October 2018): Eligibility Reinstated for Products Manufactured by Diagnostics for the Real World - SAMBA HIV-1 Semi-Q Test for use with SAMBA I Instrument and SAMBA II HIV-1 Semi-Q Test for use with SAMBA II Instrument
download in English -
Quality Assurance Information Notice 2018-04: REMEDICA Rapid Alert Notification CY/I/07/01: Falsified Quinine Sulphate tablets 300 mg
download in English | Français -
Quality Assurance Information Notice 2018-03: Temporary Delisting of Products Manufactured by Diagnostics for the Real World - SAMBA HIV-1 Semi-Q Test for use with SAMBA I Instrument and SAMBA II HIV-1 Semi-Q Test for use with SAMABA II Instrument
download in English -
Quality Assurance Information Notice 2018-02: Dolutegravir (DTG) Use in Women of Childbearing Age – Safety Communication (8 June 2018)
download in English -
Quality Assurance Information Notice 2018-01: Briefing on the Recent Changes to the Global Fund Quality Assurance Policy for Diagnostic Products with Regards to the Procurement and Testing of Malaria Rapid Diagnostic Test (RDTs)
download in English -
Quality Assurance Information Notice 2016-01: All Products Manufactured by Svizera Labs Private Limited, Turbhe, Navi, Mumbai, India - Eligibility Reinstated for Procurement with Global Fund Funds
download in English -
Quality Assurance Information Notice 2017-01: Voluntary Recall Initiated by Lupin for Isoniazid Tablets BP 100mg, Batches No A301856, A302231, A302408
download in English | Español | Français -
Quality Assurance Information Notice 2016-04: Remedica Product: Sulfadoxine / Pyrimethamine, 500/25 mg, Tablets - Eligibility Reinstated for Procurement with Global Fund Funds
download in English -
Quality Assurance Information Notice 2016-03: Hetero Labs Product: Efavirenz, Lamivudine, and Tenofovir, 600/300/300 mg Tablets - No Longer Eligible for Procurement with Global Fund Funds
download in English | Español | Français -
Quality Assurance Information Notice 2016-01: Recommendations Following WHO PQP Suspension of all the Prequalified Products Manufactured by Svizera Labs Private Limited
download in English
-
QA Information Notice 2019-06: Voluntary recall initiated by Macleods for ”Moxifloxacin Dispersible tablets 100mg - Batch No BMC5801A”